Lilly, partners release report on diabetes drug
Indianapois-based Eli Lilly and Co., along with California-based Amylin Pharmaceuticals Inc. and Massachusetts-based Alkermes Inc., released clinical trial results Monday night for their long-acting version of Byetta, a diabetes drug that analysts expect to be a big seller. The study showed that patients maintained and even improved on their lower blood sugar and weight levels […]